for the Period Ended 31 October 2025
| Directors report | |
| Balance sheet | |
| Additional notes | |
| Balance sheet notes | |
| Community Interest Report |
Directors' report period ended
The directors present their report with the financial statements of the company for the period ended 31 October 2025
Principal activities of the company
Directors
The directors shown below have held office during the whole of the period from
1 November 2024
to
31 October 2025
The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006
This report was approved by the board of directors on
And signed on behalf of the board by:
Name:
Status: Director
As at
| Notes | 2025 | 2024 | |
|---|---|---|---|
|
|
£ |
£ |
|
| Fixed assets | |||
| Tangible assets: | 3 |
|
|
| Total fixed assets: |
|
|
|
| Current assets | |||
| Debtors: | 4 |
|
|
| Cash at bank and in hand: |
|
|
|
| Total current assets: |
|
|
|
| Creditors: amounts falling due within one year: | 5 |
(
|
(
|
| Net current assets (liabilities): |
|
|
|
| Total assets less current liabilities: |
|
|
|
| Provision for liabilities: |
(
|
(
|
|
| Accruals and deferred income: |
(
|
(
|
|
| Total net assets (liabilities): |
|
|
|
| Members' funds | |||
| Profit and loss account: |
|
|
|
| Total members' funds: |
|
|
The notes form part of these financial statements
The directors have chosen not to file a copy of the company's profit and loss account.
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 October 2025
Basis of measurement and preparation
Turnover policy
Tangible fixed assets depreciation policy
Other accounting policies
for the Period Ended 31 October 2025
| 2025 | 2024 | |
|---|---|---|
| Average number of employees during the period |
|
|
for the Period Ended 31 October 2025
| Land & buildings | Plant & machinery | Fixtures & fittings | Office equipment | Motor vehicles | Total | |
|---|---|---|---|---|---|---|
| Cost | £ | £ | £ | £ | £ | £ |
| At 1 November 2024 |
|
|
||||
| Additions | ||||||
| Disposals | ||||||
| Revaluations | ||||||
| Transfers | ||||||
| At 31 October 2025 |
|
|
||||
| Depreciation | ||||||
| At 1 November 2024 |
|
|
||||
| Charge for year |
|
|
||||
| On disposals | ||||||
| Other adjustments | ||||||
| At 31 October 2025 |
|
|
||||
| Net book value | ||||||
| At 31 October 2025 |
|
|
||||
| At 31 October 2024 |
|
|
for the Period Ended 31 October 2025
| 2025 | 2024 | |
|---|---|---|
| £ | £ | |
| Trade debtors |
|
|
| Total |
|
|
for the Period Ended 31 October 2025
| 2025 | 2024 | |
|---|---|---|
| £ | £ | |
| Trade creditors |
|
|
| Taxation and social security |
|
|
| Other creditors |
|
|
| Total |
|
|
Vocal Collective CIC is a social enterprise working with communities, patients, researchers, funders, practitioners and organisations. We bring people together in inclusive and equitable partnerships, sharing professional and lived experience towards better health and society. This period covers the second year that Vocal Collective has been in existence (1 November 2024 to 31 October 2025). In this period, Vocal Collective partnered on one project (Centres for Exchange) and led a second (Engaged Research Skills and Tools). Both are funded by Wellcome and both bring benefit: Centres for Exchange develops capacity and innovation in equitable and inclusive health research by supporting community organisations to upskill themselves in research methods and knowledge production. Our work supported Phase 1 of the project, which focused on learning and design. This provided the foundations for Phase 2, which is being delivered across India, Kenya and South Africa. Engaged Research Skills and Tools is a research and learning project that supports health researchers to develop their capacity to carry out open, ethical and engaged research. The substantive part of the project was completed within this period. We also secured additional funding to share the project across Wellcome and support the learning and development of its staff. Across the project, we engaged over 30 researchers, over 20 public engagement professionals and practitioners (PEPs) and over 10 experienced public and community partners. The benefits of this project for different stakeholders and communities have been: For health researchers: the project produced the Wellcome Engaged Research Primer, a high-quality, practical resource that helps researchers develop new ways to think about, plan and deliver engaged and equitable health research with people and communities, in the UK and globally. Over 30 researchers took part in interviews, workshops and user testing of the resource, developing their knowledge, skills and confidence in engaged research. For people, patients and communities: the Engaged Research Primer supports better practice and advocates for health research that engages with people, patients and communities. Over 10 experienced public and community partners were directly involved in interviews, workshops and user testing of the resource, developing their knowledge, skills and confidence in engaged research. Indirectly, people and communities benefit because the Primer supports researchers to tackle perennial challenges within research that underpin health and social inequalities. The Primer addresses these inequalities by improving knowledge and practical skills for individuals, groups and the research sector; promoting diversity among the people who fund, design and take part in research; and supporting fair, ethical and inclusive ways of working together as part of excellent health research, and improved health outcomes. For public engagement professionals and practitioners (PEPs): the Engaged Research Primer compiles knowledge, skills and activities that help PEPs support researchers towards more engaged research and, ultimately, better and more equitable health outcomes. Over 20 PEPs were engaged in its development. For Wellcome and other funders of health research: the Engaged Research Primer is hosted on the Wellcome website as funding application guidance for the research community. Wellcome agreed to fund Vocal Collective CIC and our partners to deliver learning and development sessions with its staff, to maximise the learning and impact of the work. Since the end of this period, the Primer has also been shared by the Medical Research Council, the National Co-ordinating Centre for Public Engagement and others.
Stakeholders for Vocal Collective include: healthcare and health research organisations; pharmaceutical and life science industries; higher education institutions; funders and policy partners; VCFSE and patient organisations; and individual patients and community partners. Stakeholders we have engaged with this year include: Wellcome, UK Research and Innovation, Research Ireland, the National Institute for Health and Care Research, Manchester University NHS Foundation Trust, the Ada Lovelace Institute, Pivot Collective, Science Ceilidh, Mabadiliko CIC, Restless Development, the Academy of Medical Sciences, the Medical Research Foundation, the Medical Research Council, the University of Oxford and Nifty Fox Creative. Through these interactions, Vocal Collective has shared knowledge and intelligence between people & communities and the research sector, worked together with stakeholders to generate ideas and deliver projects. As part of developing the Wellcome Engaged Research Primer, Vocal Collective gathered research data and insights into what different stakeholder groups need to support them with engaged research. This included input from researchers, PEPs, research funders, and people and patients with lived and living experience relating to health research. Their input shaped the initial scope of the Primer and its language, content and format. A further stage of user testing then refined the final output. During this year, Vocal Collective CIC also grew its network of Associates and developed funding proposals within these partnerships, alongside ongoing business development.
No remuneration was received
No transfer of assets other than for full consideration
This report was approved by the board of directors on
27 October 2026
And signed on behalf of the board by:
Name: Leah Holmes
Status: Director